In drug formulations for external application, variations in the state of pharmaceutical agents within the base formulation may affect the transfer of agents to the skin. Here, we use Raman spectroscopic methods to acquire more detailed information on the state of the active pharmaceutical ingredients within an externally applied formulation. The combination of wide-field Raman spectroscopy with an experimental method in which drug formulations are applied to glass surfaces provided a new method for characterizing the state of pharmaceutical agents within drug formulations. Here, we demonstrate the usefulness of this new method, called application to glass-wide-field Raman spectroscopy (AG-WRS). In addition to allowing rapid and easy wide-field observations, the use of WRS allows Raman imaging in a manner that is insensitive to variations in the thickness of the formulations applied to sample slides. We consider two types of urea-compound creams with different crystal deposition rates, using AG-WRS to characterize the post-application timeevolving state of deposited crystals. Differences in the base pharmaceutical produce different spectra for the deposits, indicating that the deposits differ in composition and structure. In addition, we use microscopic laser Raman measurements to demonstrate that the process of crystal formulation differs significantly for formulations with different compositions. Our results demonstrate that the combination of AG-WRS with existing analytical techniques such as powder X-ray diffraction or thermal analysis yields more detailed and timely post-application information on the state of pharmaceuticals in external application. We believe this will be a valuable analytical tool for future studies related to the development of external application.Key words urea; wide field Raman scope; crystallization; analytical method; Raman imaging; creamIn studies related to the development of external application, detailed knowledge of the state of the active pharmaceutical ingredients within the drug formulation is important for determining whether or not the pharmaceutical components can properly exert their intended effect. For crystalline pharmaceuticals in particular, crystallization that occurs a short time after application-as well, of course, as crystallization that occurs within the formulation itself-can degrade the efficiency of transfer to the stratum corneum, making it difficult to achieve clinical effectiveness.
1-3)Methods for the qualitative or quantitative characterization of the crystallization of active pharmaceutical ingredients within drug formulations include Raman spectroscopy, near-infrared (NIR) spectroscopy, powder X-ray diffraction (PXRD), solid-state NMR, and terahertz spectroscopy, and many reports using these methods have appeared to date.
4-11)In recent years, the ease with which characteristic peaks associated with various crystal structures of active pharmaceutical ingredients may be obtained has stimulated many studies using Raman spectroscopy 12) and PXRD. 13,14...